JH

Jaclyn Louise Henderson

Pfizer: 18 patents #185 of 5,153Top 4%
📍 Cambridge, MA: #568 of 8,183 inventorsTop 7%
🗺 Massachusetts: #6,479 of 88,656 inventorsTop 8%
Overall (All Time): #249,317 of 4,157,543Top 6%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
11964961 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2024-04-23
11390623 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Thomas Allen Chappie, Joseph Michael Young, Travis T. Wager, Bethany Lyn Kormos, Nandini Chaturbhai Patel +4 more 2022-07-19
11312713 Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Michael Aaron Brodney, Thomas Allen Chappie, Jinshan Chen, Jotham Wadsworth Coe, Karen Coffman +14 more 2022-04-26
11161844 Cyclic substituted imidazo[4,5-c]quinoline derivatives Thomas Allen Chappie, Paul Galatsis, Michelle Renee Garnsey, Christopher John Helal, Bethany Lyn Kormos +5 more 2021-11-02
11014909 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2021-05-25
10696658 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2020-06-30
10590128 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Thomas Allen Chappie, Joseph Michael Young, Travis T. Wager, Bethany Lyn Kormos, Nandini Chaturbhai Patel +4 more 2020-03-17
10421744 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2019-09-24
10093655 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2018-10-09
10039753 Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors Karen Coffman, Paul Galatsis, Michelle Renee Garnsey, Bethany Lyn Kormos, Ravi G. Kurumbail +5 more 2018-08-07
9822097 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2017-11-21
9695171 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Travis T. Wager, Lei Zhang +3 more 2017-07-04
9642855 Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Travis T. Wager, Lei Zhang +3 more 2017-05-09
9617275 Heteroaromatic compounds and their use as dopamine D1 ligands Jotham Wadsworth Coe, John Arthur Allen, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +9 more 2017-04-11
9527831 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2016-12-27
9156845 4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Travis T. Wager, Lei Zhang +3 more 2015-10-13
9139561 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2015-09-22
9107923 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2015-08-18